Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$26.1M |
| 2 |
Philip Morris
PM
|
+$8.52M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$5.55M |
| 4 |
C.H. Robinson
CHRW
|
+$3.79M |
| 5 |
Medtronic
MDT
|
+$3.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$1.58M |
| 2 |
Valvoline
VVV
|
+$1.07M |
| 3 |
Compañía de Cervecerías Unidas
CCU
|
+$553K |
| 4 |
Mitek Systems
MITK
|
+$119K |
| 5 |
Booking.com
BKNG
|
+$111K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 19.34% |
| 3 | Industrials | 15.72% |
| 4 | Financials | 13.9% |
| 5 | Consumer Staples | 8.78% |
Similar funds
Foyston, Gordon, & Payne's Q3 2022 Portfolio in Review
As of Q3 2022, Foyston, Gordon, & Payne held 66 positions worth $365M, up 5.5% from $346M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Foyston, Gordon, & Payne deployed $98.2M of net new capital in Q3 2022, opening 4 new positions and adding to 42 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 670,061 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $111K trimmed.
- Foyston, Gordon, & Payne's largest Q3 2022 buy was iShares MSCI Emerging Markets ETF: 670,061 shares worth $23.4M.
- Foyston, Gordon, & Payne added most to Philip Morris in Q3 2022, an estimated $8.52M increase.
- Foyston, Gordon, & Payne's biggest Q3 2022 reduction was Booking.com, cutting an estimated $111K.
- Foyston, Gordon, & Payne fully exited Corteva in Q3 2022, selling an estimated $1.58M.
- Foyston, Gordon, & Payne's ten largest holdings make up 43% of its $365M portfolio in Q3 2022.
- Foyston, Gordon, & Payne opened 4 new positions and closed 4 in Q3 2022.
- Foyston, Gordon, & Payne's portfolio value rose 5.5% quarter-over-quarter to $365M.
Based on Foyston, Gordon, & Payne's 13F filing for Q3 2022, filed 4 Nov 2022.